z-logo
open-access-imgOpen Access
CdpA Is a Burkholderia pseudomallei Cyclic di-GMP Phosphodiesterase Involved in Autoaggregation, Flagellum Synthesis, Motility, Biofilm Formation, Cell Invasion, and Cytotoxicity
Author(s) -
Hwee Siang Lee,
Feiyu Gu,
Shi Min Ching,
Yulin Lam,
Kim Lee Chua
Publication year - 2010
Publication title -
infection and immunity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 220
eISSN - 1070-6313
pISSN - 0019-9567
DOI - 10.1128/iai.00446-09
Subject(s) - biology , burkholderia pseudomallei , biofilm , microbiology and biotechnology , intracellular , mutant , biochemistry , bacteria , gene , genetics
Cyclic diguanylic acid (c-di-GMP) is an intracellular signaling molecule involved in regulation of cellular functions such as motility, biofilm formation and virulence. Intracellular level of c-di-GMP is controlled through opposing diguanylate cyclase (DGC) and phosphodiesterase (PDE) activities of GGDEF and EAL domain proteins, respectively. We report the identification and characterization ofcdpA , a gene encoding a protein containing an EAL domain in the Gram-negative soil bacillus and human pathogenBurkholderia pseudomallei KHW. Purified recombinant CdpA protein exhibited PDE activityin vitro . Evidence that CdpA is a major c-di-GMP-specific PDE inB. pseudomallei KHW was shown by an 8-fold-higher c-di-GMP level in thecdpA- null mutant as compared to the wild type and the complementedcdpA mutant. The presence of higher intracellular c-di-GMP levels in thecdpA- null mutant was associated with increased production of exopolysaccharides, increased cell-to-cell aggregation, absence of flagella and swimming motility, and increased biofilm formation. The relevance of CdpA inB. pseudomallei virulence was demonstrated by a 3-fold reduction in invasion of human lung epithelial cells and a 6-fold reduction in cytotoxicity on human macrophage cells infected with thecdpA mutant.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here